Merck KGaA Agrees to Buy Bio-Techne for $11.3 Billion
2026-06-25 11:01:59
Merck KGaA agreed to buy Bio-Techne Corporation for $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
